Inactive Instrument

Company Stentys

Equities

STNT

FR0010949404

Medical Equipment, Supplies & Distribution

Business Summary

Stentys SA is a French-based company specialized in the development of a new generation of stents for the treatment of acute myocardial infarction or coronary artery disease. It's main product STENTYS Stent, self-expanding coronary bare-metal stent system, is indicated for the treatment of Acute Coronary Syndrome. The Company's institutional shareholders are Sofinnova Partners, Credit Agricole Private Equity and Scottish Equity Partners. In June 2014, it acquired Cappella Peel Away Inc.

Number of employees: 26

Managers

Managers TitleAgeSince
Chief Executive Officer 74 10-11-18
Public Communications Contact - 14-02-28
Sales & Marketing - 18-06-30
Sales & Marketing - 11-04-30

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 74 10-11-18
Director/Board Member 63 14-02-02
Director/Board Member 68 17-03-30
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -
Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,824,657 26,805,915 ( 99.93 %) 18,742 ( 0.0699 %) 99.93 %

Company contact information

Stentys SA

171 bis, avenue Charles de Gaulle Bât C

92200, Neuilly-sur-Seine

+

http://www.stentys.com
address Stentys(STNT)